Immutep targets $100m for lung cancer drug trial tests
Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IRE | Ann: Change of Director's Interest Notice | 03/06/24 | 0 | 83 | |||
|
|||||||
IRE | Ann: Notification regarding unquoted securities - IRE | 03/06/24 | 0 | 100 | |||
|
|||||||
IRE | Iress: Slimmer, but stronger? Intelligent Investor Research | 28/05/24 | 0 | 195 | |||
|
|||||||
IRE | Ann: Becoming a substantial holder | 27/05/24 | 0 | 175 | |||
|
|||||||
IRE | Ann: Ceasing to be a substantial holder | 20/05/24 | 0 | 188 | |||
|
|||||||
IRE | Ann: Becoming a substantial holder | 17/05/24 | 0 | 166 | |||
|
|||||||
IRE | Ann: Further update on Iress unauthorised access incident | 17/05/24 | 0 | 243 | |||
|
|||||||
IRE | News: IRE Iress Updates On Iress Unauthorised Access Incident | 17/05/24 | 0 | 134 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |